Trade ImmuCell - ICCC CFD
Add to favourite- Summary
- Historical Data
Spread | 0.05 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023374% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001151% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 4.58 |
Open | 4.49 |
1-Year Change | -0.22% |
Day's Range | 4.4 - 4.49 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 20, 2024 | 4.40 | -0.09 | -2.00% | 4.49 | 4.49 | 4.40 |
Dec 19, 2024 | 4.58 | -0.01 | -0.22% | 4.59 | 4.86 | 4.57 |
Dec 18, 2024 | 4.44 | -0.37 | -7.69% | 4.81 | 4.92 | 4.44 |
Dec 17, 2024 | 4.84 | 0.40 | 9.01% | 4.44 | 5.05 | 4.44 |
Dec 16, 2024 | 4.68 | 0.06 | 1.30% | 4.62 | 4.68 | 4.62 |
Dec 13, 2024 | 4.79 | 0.38 | 8.62% | 4.41 | 4.98 | 4.40 |
Dec 12, 2024 | 4.51 | -0.02 | -0.44% | 4.53 | 4.77 | 4.51 |
Dec 11, 2024 | 4.85 | 0.11 | 2.32% | 4.74 | 5.84 | 4.74 |
Dec 10, 2024 | 4.66 | -0.22 | -4.51% | 4.88 | 4.89 | 4.61 |
Dec 9, 2024 | 4.84 | -0.02 | -0.41% | 4.86 | 5.02 | 4.81 |
Dec 6, 2024 | 4.69 | 0.22 | 4.92% | 4.47 | 4.69 | 4.39 |
Dec 5, 2024 | 4.45 | -0.24 | -5.12% | 4.69 | 4.75 | 4.44 |
Dec 4, 2024 | 4.82 | 0.23 | 5.01% | 4.59 | 5.14 | 4.58 |
Dec 3, 2024 | 4.37 | 0.16 | 3.80% | 4.21 | 4.55 | 4.10 |
Dec 2, 2024 | 4.17 | 0.17 | 4.25% | 4.00 | 4.29 | 4.00 |
Nov 29, 2024 | 3.99 | 0.30 | 8.13% | 3.69 | 4.14 | 3.69 |
Nov 27, 2024 | 3.70 | 0.10 | 2.78% | 3.60 | 3.73 | 3.54 |
Nov 26, 2024 | 3.67 | -0.03 | -0.81% | 3.70 | 3.72 | 3.60 |
Nov 25, 2024 | 3.73 | 0.06 | 1.63% | 3.67 | 3.75 | 3.60 |
Nov 22, 2024 | 3.68 | 0.04 | 1.10% | 3.64 | 3.70 | 3.56 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
ImmuCell Company profile
About ImmuCell Corporation
ImmuCell Corporation is an animal health company. The Company is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. It manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. It expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The Company is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.
Financial summary
BRIEF: For the nine months ended 30 September 2021, ImmuCell Corporation revenues increased 19% to $13.8M. Net loss decreased 87% to $152K. Revenues reflect First Defense® product line segment increase of 44% to $9.5M, Other animal health segment increase of 83% to $186K, United States segment increase of 18% to $12.2M, Others segment increase of 28% to $1.6M.
Equity composition
Common Stock $.10 Par, 12/10, 8M auth., 3,261,148 issd., less 287,496 shs. in Treas. @ $635K. Insiders own 26.70%. PO 5/87, 966,000 Units (100 Common + 5 Warrants) @ $7/Unit by Stuart James. 7/90, 1-for-100 reverse stock split.
Industry: | Biotechnology & Medical Research (NEC) |
56 Evergreen Drive
PORTLAND
MAINE 04103
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com